Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

275.67 -0.06 (-0.02%)

Streaming Delayed Price Updated: 11:22 AM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	105,779
Open	279.48
Bid (Size)	274.10 (100)
Ask (Size)	277.23 (100)
Prev. Close	275.73
Today's Range	270.01 - 279.48
52wk Range	26.70 - 286.50
Shares Outstanding	44,712,538
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026

December 11, 2025

EMBOLD data to serve as basis of efficacy and safety following discussion with the FDA

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy

December 09, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Performance

YTD	+246.7%	+246.7%
1 Month	+44.4%	+44.4%
3 Month	+467.2%	+467.2%
6 Month	+527.1%	+527.1%
1 Year	+255.4%	+255.4%

More News

Praxis AES Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies

December 08, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position ↗

November 20, 2025

Via Stocktwits

What's going on in today's session ↗

December 05, 2025

Via Chartmill

Top movers analysis in the middle of the day on 2025-12-05: top gainers and losers in today's session. ↗

December 05, 2025

Via Chartmill

The market is filled with gapping stocks in Friday's session. ↗

December 05, 2025

Via Chartmill

What's going on in today's pre-market session ↗

December 05, 2025

Via Chartmill

Why Did PRAX Stock Rocket 24% Pre-Market Today? ↗

December 05, 2025

Via Stocktwits

Praxis Precision Medicines Stock Surges 25% In Friday Pre-Market Trading— What's Going On? ↗

December 05, 2025

Via Benzinga

Nasdaq, S&P 500 Futures Set For Firm Open Ahead Of PCE Inflation Data: Why NFLX, SMX, SOFI, IOT Are On Traders' Radar ↗

December 05, 2025

Via Stocktwits

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

December 04, 2025

Via Chartmill

Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies

December 04, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor

December 04, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 03, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis to present latest preclinical and clinical advancements across leading epilepsy portfolio at the 2025 American Epilepsy Society (AES) Annual Meeting

November 24, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

November 20, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Short Seller Alleges Praxis Precision's Potential $3 Billion Drug 'A House Of Cards' ↗

November 20, 2025

Via Benzinga

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

Via MarketMinute

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 06, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Participate in Upcoming Investor Conferences

November 05, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results

November 05, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis announces accelerated development path for relutrigine in SCN2A and SCN8A DEE patients following positive FDA feedback

November 04, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 03, 2025

Via Benzinga

Meet the Biotech Stock That Just Jumped 251% Higher ↗

October 26, 2025

Via The Motley Fool

Frequently Asked Questions

Is Praxis Precision Medicines, Inc. - Common Stock publicly traded?

Yes, Praxis Precision Medicines, Inc. - Common Stock is publicly traded.

What exchange does Praxis Precision Medicines, Inc. - Common Stock trade on?

Praxis Precision Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Praxis Precision Medicines, Inc. - Common Stock?

The ticker symbol for Praxis Precision Medicines, Inc. - Common Stock is PRAX on the Nasdaq Stock Market

What is the current price of Praxis Precision Medicines, Inc. - Common Stock?

The current price of Praxis Precision Medicines, Inc. - Common Stock is 275.67

When was Praxis Precision Medicines, Inc. - Common Stock last traded?

The last trade of Praxis Precision Medicines, Inc. - Common Stock was at 12/24/25 11:22 AM ET

What is the market capitalization of Praxis Precision Medicines, Inc. - Common Stock?

The market capitalization of Praxis Precision Medicines, Inc. - Common Stock is 12.33B

How many shares of Praxis Precision Medicines, Inc. - Common Stock are outstanding?

Praxis Precision Medicines, Inc. - Common Stock has 12B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.